Hyundai Motor Co. is targeting sales of 10,100 Nexo hydrogen fuel cell electric vehicles in South Korea, mainly to public organizations and companies.
It sold 4,194 units in 2019.
The company has so far sold over 10,000 Nexo hydrogen fuel cell electric vehicles in South Korea since its launch in early 2018.
On top of its local sales, Hyundai has so far exported 1,841 Nexos since March 2018.
Hyundai is slated to develop more hydrogen-powered commercial vehicles, such as buses and trucks to fortify its leading position in hydrogen vehicles.
It has recently begun exporting hydrogen-powered trucks and buses.
The company would build a production facility capable of manufacturing 50,000 hydrogen-powered vehicles a year by 2030.
Hyundai also targets annual global sales of 200,000 hydrogen fuel cell systems a year during the same


HSBC’s $13.6 Billion Take-Private Offer for Hang Seng Bank Gains Board Backing
Ford Takes $19.5 Billion Charge as EV Strategy Shifts Toward Hybrids
Mizuho Raises Broadcom Price Target to $450 on Surging AI Chip Demand
Korea Zinc to Build $7.4 Billion Critical Minerals Refinery in Tennessee With U.S. Government Backing
SpaceX Insider Share Sale Values Company Near $800 Billion Amid IPO Speculation
JD.com Pledges 22 Billion Yuan Housing Support for Couriers as China’s Instant Retail Competition Heats Up
Nvidia Weighs Expanding H200 AI Chip Production as China Demand Surges
Fortescue Expands Copper Portfolio With Full Takeover of Alta Copper
SpaceX Begins IPO Preparations as Wall Street Banks Line Up for Advisory Roles
Air Force One Delivery Delayed to 2028 as Boeing Faces Rising Costs
FAA Unveils Flight Plan 2026 to Strengthen Aviation Safety and Workforce Development
United Airlines Flight to Tokyo Returns to Dulles After Engine Failure During Takeoff
Intel’s Testing of China-Linked Chipmaking Tools Raises U.S. National Security Concerns
Korea Zinc Plans $6.78 Billion U.S. Smelter Investment With Government Partnership
Coca-Cola’s Proposed Sale of Costa Coffee Faces Uncertainty Amid Price Dispute
California Jury Awards $40 Million in Johnson & Johnson Talc Cancer Lawsuit 



